Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Olfaction Disorders | 19 | 2023 | 224 | 4.120 |
Why?
|
Olfactory Mucosa | 15 | 2022 | 99 | 2.750 |
Why?
|
Olfactory Bulb | 7 | 2023 | 198 | 2.310 |
Why?
|
Smell | 11 | 2023 | 259 | 2.050 |
Why?
|
Sinusitis | 20 | 2023 | 990 | 1.830 |
Why?
|
Rhinitis | 17 | 2023 | 746 | 1.630 |
Why?
|
Olfactory Receptor Neurons | 4 | 2022 | 96 | 1.590 |
Why?
|
Paranasal Sinus Diseases | 5 | 2015 | 121 | 1.140 |
Why?
|
Paranasal Sinus Neoplasms | 5 | 2023 | 241 | 1.070 |
Why?
|
Endoscopy | 16 | 2023 | 1838 | 1.050 |
Why?
|
Esthesioneuroblastoma, Olfactory | 3 | 2023 | 58 | 1.030 |
Why?
|
Nasal Cavity | 6 | 2024 | 304 | 1.030 |
Why?
|
Epistaxis | 5 | 2020 | 111 | 0.920 |
Why?
|
Nose Neoplasms | 3 | 2023 | 249 | 0.860 |
Why?
|
Rodentia | 1 | 2023 | 260 | 0.760 |
Why?
|
Coloring Agents | 1 | 2023 | 562 | 0.700 |
Why?
|
Cranial Nerves | 1 | 2019 | 98 | 0.660 |
Why?
|
Implantable Neurostimulators | 1 | 2019 | 72 | 0.650 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 3 | 2022 | 141 | 0.580 |
Why?
|
Hydrocarbons, Brominated | 1 | 2014 | 29 | 0.480 |
Why?
|
Turbinates | 4 | 2019 | 64 | 0.480 |
Why?
|
Paranasal Sinuses | 7 | 2021 | 265 | 0.450 |
Why?
|
Nasal Polyps | 6 | 2018 | 395 | 0.450 |
Why?
|
Frontal Sinus | 1 | 2013 | 51 | 0.450 |
Why?
|
Electric Stimulation Therapy | 1 | 2018 | 613 | 0.420 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2012 | 87 | 0.410 |
Why?
|
Quality of Life | 15 | 2023 | 13308 | 0.390 |
Why?
|
Maxillary Sinus | 4 | 2023 | 180 | 0.390 |
Why?
|
Skull Base | 2 | 2022 | 291 | 0.380 |
Why?
|
Hematoma | 2 | 2013 | 769 | 0.370 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3085 | 0.360 |
Why?
|
Intracranial Pressure | 1 | 2012 | 325 | 0.360 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3205 | 0.350 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 3 | 2020 | 323 | 0.340 |
Why?
|
Sensory Receptor Cells | 1 | 2014 | 509 | 0.330 |
Why?
|
Bone Transplantation | 1 | 2013 | 922 | 0.310 |
Why?
|
Biopsy | 4 | 2016 | 6771 | 0.280 |
Why?
|
Nose Diseases | 2 | 2020 | 79 | 0.270 |
Why?
|
Nerve Regeneration | 4 | 2018 | 790 | 0.270 |
Why?
|
Neural Stem Cells | 3 | 2019 | 884 | 0.270 |
Why?
|
Chronic Disease | 16 | 2023 | 9288 | 0.270 |
Why?
|
Mycoses | 1 | 2009 | 387 | 0.260 |
Why?
|
Nose | 3 | 2024 | 519 | 0.260 |
Why?
|
Diagnostic Errors | 1 | 2013 | 1266 | 0.250 |
Why?
|
Otolaryngology | 3 | 2020 | 685 | 0.250 |
Why?
|
Rhinoplasty | 2 | 2019 | 238 | 0.250 |
Why?
|
Natural Orifice Endoscopic Surgery | 2 | 2019 | 119 | 0.250 |
Why?
|
Surgical Flaps | 1 | 2013 | 1669 | 0.240 |
Why?
|
Toxins, Biological | 1 | 2004 | 61 | 0.240 |
Why?
|
Ligation | 3 | 2020 | 448 | 0.230 |
Why?
|
Maxillary Sinusitis | 1 | 2023 | 41 | 0.220 |
Why?
|
Nasal Mucosa | 3 | 2015 | 412 | 0.210 |
Why?
|
Humans | 75 | 2024 | 760613 | 0.210 |
Why?
|
Embolization, Therapeutic | 1 | 2012 | 1412 | 0.210 |
Why?
|
Hypersensitivity | 2 | 2022 | 1155 | 0.210 |
Why?
|
Olfactory Perception | 2 | 2020 | 65 | 0.210 |
Why?
|
Toll-Like Receptor 3 | 2 | 2015 | 98 | 0.200 |
Why?
|
Cautery | 2 | 2020 | 71 | 0.200 |
Why?
|
Metaplasia | 1 | 2022 | 320 | 0.190 |
Why?
|
Carcinoma | 2 | 2014 | 2331 | 0.190 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2022 | 86 | 0.180 |
Why?
|
Immunohistochemistry | 4 | 2011 | 11070 | 0.180 |
Why?
|
Aerosols | 2 | 2020 | 632 | 0.180 |
Why?
|
Aged | 28 | 2023 | 169143 | 0.180 |
Why?
|
Axons | 3 | 2005 | 1672 | 0.180 |
Why?
|
Skull Base Neoplasms | 1 | 2024 | 269 | 0.180 |
Why?
|
Dysgeusia | 1 | 2020 | 15 | 0.180 |
Why?
|
Nasal Septum | 2 | 2019 | 130 | 0.180 |
Why?
|
Olfactory Marker Protein | 3 | 2016 | 12 | 0.180 |
Why?
|
Metals | 1 | 2004 | 736 | 0.170 |
Why?
|
Medication Therapy Management | 1 | 2021 | 132 | 0.170 |
Why?
|
Melanosis | 1 | 2021 | 93 | 0.170 |
Why?
|
Peroxidase | 1 | 2023 | 605 | 0.170 |
Why?
|
Otitis Media | 1 | 2022 | 285 | 0.170 |
Why?
|
Ethmoid Bone | 1 | 2018 | 35 | 0.160 |
Why?
|
Middle Aged | 36 | 2023 | 220359 | 0.160 |
Why?
|
Staining and Labeling | 1 | 2023 | 1089 | 0.150 |
Why?
|
Optic Nerve Diseases | 1 | 2022 | 342 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2022 | 407 | 0.150 |
Why?
|
Postoperative Complications | 4 | 2018 | 15679 | 0.150 |
Why?
|
Hyperplasia | 1 | 2021 | 1155 | 0.150 |
Why?
|
Vitamin A | 1 | 2021 | 613 | 0.150 |
Why?
|
Olfactory Nerve | 3 | 2006 | 21 | 0.150 |
Why?
|
Adult | 30 | 2023 | 220007 | 0.150 |
Why?
|
Melanocytes | 1 | 2021 | 512 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
Male | 42 | 2023 | 359718 | 0.140 |
Why?
|
Nasal Obstruction | 1 | 2019 | 159 | 0.140 |
Why?
|
Cocaine | 1 | 2022 | 961 | 0.140 |
Why?
|
Meningomyelocele | 1 | 2018 | 170 | 0.140 |
Why?
|
Verapamil | 1 | 2017 | 242 | 0.130 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 651 | 0.130 |
Why?
|
Graves Ophthalmopathy | 1 | 2018 | 133 | 0.130 |
Why?
|
Papilloma, Inverted | 1 | 2015 | 19 | 0.130 |
Why?
|
Dacryocystorhinostomy | 1 | 2016 | 78 | 0.130 |
Why?
|
Steroids | 1 | 2021 | 928 | 0.130 |
Why?
|
S100 Proteins | 1 | 2016 | 218 | 0.120 |
Why?
|
Enophthalmos | 1 | 2015 | 34 | 0.120 |
Why?
|
Neurogenesis | 2 | 2019 | 855 | 0.120 |
Why?
|
Meningioma | 1 | 2024 | 1221 | 0.120 |
Why?
|
Treatment Outcome | 15 | 2024 | 64981 | 0.120 |
Why?
|
Female | 38 | 2023 | 391246 | 0.120 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2016 | 198 | 0.120 |
Why?
|
Meningeal Neoplasms | 1 | 2024 | 1249 | 0.120 |
Why?
|
Mice, Congenic | 1 | 2014 | 97 | 0.120 |
Why?
|
Neurons | 3 | 2023 | 9424 | 0.120 |
Why?
|
Thyroid Neoplasms | 1 | 2008 | 2332 | 0.120 |
Why?
|
Cells | 1 | 1995 | 164 | 0.120 |
Why?
|
Quality Improvement | 2 | 2020 | 3835 | 0.120 |
Why?
|
Eye Infections, Fungal | 1 | 2015 | 100 | 0.120 |
Why?
|
Mucormycosis | 1 | 2015 | 103 | 0.120 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2014 | 39 | 0.110 |
Why?
|
Airway Remodeling | 1 | 2015 | 134 | 0.110 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 446 | 0.110 |
Why?
|
Neurofilament Proteins | 1 | 2016 | 333 | 0.110 |
Why?
|
Activins | 1 | 2015 | 211 | 0.110 |
Why?
|
Catheterization | 1 | 2019 | 1432 | 0.110 |
Why?
|
Pneumoencephalography | 1 | 2012 | 22 | 0.110 |
Why?
|
Aspergillosis | 1 | 2015 | 243 | 0.110 |
Why?
|
Synaptic Transmission | 1 | 2019 | 1171 | 0.110 |
Why?
|
Orbital Diseases | 1 | 2015 | 178 | 0.110 |
Why?
|
Maxillary Artery | 1 | 2012 | 18 | 0.110 |
Why?
|
Decompression, Surgical | 1 | 2018 | 604 | 0.110 |
Why?
|
Olfactory Nerve Diseases | 1 | 2012 | 1 | 0.110 |
Why?
|
Anti-Bacterial Agents | 4 | 2022 | 7408 | 0.110 |
Why?
|
Pandemics | 6 | 2023 | 8623 | 0.100 |
Why?
|
Diagnosis, Differential | 6 | 2012 | 12968 | 0.100 |
Why?
|
Biological Products | 1 | 2021 | 916 | 0.100 |
Why?
|
Tubulin | 1 | 2016 | 692 | 0.100 |
Why?
|
Animals | 12 | 2023 | 167960 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1869 | 0.100 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 60 | 0.100 |
Why?
|
Orbit | 1 | 2015 | 446 | 0.100 |
Why?
|
Office Visits | 1 | 2016 | 597 | 0.100 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 608 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 7 | 2013 | 20509 | 0.090 |
Why?
|
Hamartoma | 1 | 2013 | 235 | 0.090 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2015 | 470 | 0.090 |
Why?
|
Headache | 1 | 2018 | 1249 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1601 | 0.090 |
Why?
|
Proteoglycans | 1 | 2013 | 801 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 830 | 0.090 |
Why?
|
Environmental Exposure | 1 | 2004 | 4412 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2014 | 968 | 0.080 |
Why?
|
Complex Mixtures | 1 | 2008 | 29 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9278 | 0.080 |
Why?
|
Recovery of Function | 1 | 2018 | 2985 | 0.080 |
Why?
|
Graft Survival | 2 | 2013 | 3795 | 0.080 |
Why?
|
Microscopy, Electron | 2 | 2005 | 2558 | 0.080 |
Why?
|
Chemokine CCL5 | 1 | 2008 | 215 | 0.080 |
Why?
|
Aged, 80 and over | 9 | 2018 | 58980 | 0.070 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 1274 | 0.070 |
Why?
|
Consensus | 3 | 2022 | 3113 | 0.070 |
Why?
|
Mice | 6 | 2023 | 81209 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39262 | 0.070 |
Why?
|
Faculty, Medical | 1 | 2015 | 1192 | 0.070 |
Why?
|
Prospective Studies | 10 | 2023 | 54306 | 0.070 |
Why?
|
Physical Examination | 1 | 2012 | 1244 | 0.070 |
Why?
|
Debridement | 2 | 2022 | 492 | 0.070 |
Why?
|
Cadaver | 2 | 2020 | 1345 | 0.070 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9530 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7475 | 0.060 |
Why?
|
Blood Transfusion | 1 | 2012 | 1328 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1344 | 0.060 |
Why?
|
Young Adult | 7 | 2019 | 58748 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8556 | 0.060 |
Why?
|
Atlanto-Axial Joint | 1 | 2005 | 60 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2782 | 0.060 |
Why?
|
Neurodegenerative Diseases | 2 | 2021 | 1084 | 0.060 |
Why?
|
Sensory Thresholds | 1 | 2006 | 377 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2016 | 4408 | 0.060 |
Why?
|
Aging | 2 | 2018 | 8652 | 0.060 |
Why?
|
Sensation | 1 | 2006 | 331 | 0.060 |
Why?
|
Prognosis | 4 | 2018 | 29661 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2024 | 80345 | 0.060 |
Why?
|
Glycoproteins | 1 | 2011 | 2208 | 0.060 |
Why?
|
Neuroma | 1 | 2005 | 133 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2290 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15840 | 0.050 |
Why?
|
Tobacco Smoke Pollution | 1 | 2008 | 812 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5697 | 0.050 |
Why?
|
Reoperation | 1 | 2012 | 4289 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2014 | 1607 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11481 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5799 | 0.050 |
Why?
|
Wounds, Stab | 1 | 2001 | 72 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2003 | 461 | 0.050 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2001 | 122 | 0.050 |
Why?
|
Sneezing | 1 | 2020 | 17 | 0.050 |
Why?
|
Neck | 1 | 2005 | 731 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2023 | 597 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2021 | 383 | 0.040 |
Why?
|
Graft Rejection | 1 | 2013 | 4426 | 0.040 |
Why?
|
Tampons, Surgical | 1 | 2020 | 10 | 0.040 |
Why?
|
Hallucinations | 1 | 2023 | 366 | 0.040 |
Why?
|
Delphi Technique | 1 | 2023 | 829 | 0.040 |
Why?
|
Software | 1 | 2014 | 4419 | 0.040 |
Why?
|
GAP-43 Protein | 2 | 2013 | 152 | 0.040 |
Why?
|
Cohort Studies | 4 | 2015 | 41337 | 0.040 |
Why?
|
Taste | 1 | 2020 | 188 | 0.040 |
Why?
|
Optic Nerve | 1 | 2022 | 567 | 0.040 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3696 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9073 | 0.040 |
Why?
|
Nerve Degeneration | 2 | 2018 | 748 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2006 | 1007 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2021 | 657 | 0.040 |
Why?
|
Patient Satisfaction | 3 | 2014 | 3448 | 0.040 |
Why?
|
Risk Factors | 6 | 2020 | 74333 | 0.040 |
Why?
|
Diphtheria Toxin | 1 | 2018 | 252 | 0.040 |
Why?
|
Theophylline | 1 | 2017 | 131 | 0.040 |
Why?
|
Hemostatics | 1 | 2020 | 243 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 6965 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2008 | 3663 | 0.030 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2017 | 214 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2013 | 36286 | 0.030 |
Why?
|
Research Design | 2 | 2023 | 6180 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2021 | 1832 | 0.030 |
Why?
|
Preoperative Care | 1 | 2005 | 2255 | 0.030 |
Why?
|
Tretinoin | 1 | 2019 | 519 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22020 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15286 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1644 | 0.030 |
Why?
|
Electrophoresis | 1 | 1995 | 234 | 0.030 |
Why?
|
Regression Analysis | 1 | 2005 | 6359 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1131 | 0.030 |
Why?
|
Mucorales | 1 | 2015 | 35 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 92 | 0.030 |
Why?
|
Activities of Daily Living | 2 | 2014 | 2417 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1578 | 0.030 |
Why?
|
Needs Assessment | 1 | 2021 | 1139 | 0.030 |
Why?
|
Schizophrenia | 1 | 2013 | 6915 | 0.030 |
Why?
|
Risk | 2 | 2017 | 9632 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 166 | 0.030 |
Why?
|
Receptors, N-Acetylglucosamine | 1 | 2013 | 11 | 0.030 |
Why?
|
Versicans | 1 | 2013 | 40 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1818 | 0.030 |
Why?
|
Brain Injuries | 1 | 2006 | 2044 | 0.030 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2013 | 18 | 0.030 |
Why?
|
Time Factors | 4 | 2023 | 40139 | 0.030 |
Why?
|
Recurrence | 2 | 2020 | 8483 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2017 | 22052 | 0.030 |
Why?
|
Plant Lectins | 1 | 2013 | 103 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 2016 | 377 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21391 | 0.030 |
Why?
|
Private Practice | 1 | 2014 | 152 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1596 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10755 | 0.030 |
Why?
|
Gryllidae | 1 | 1992 | 19 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2167 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 13982 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1940 | 0.030 |
Why?
|
Hospitals, University | 1 | 2014 | 568 | 0.030 |
Why?
|
Transcription Factors | 1 | 2011 | 12102 | 0.020 |
Why?
|
Bandages | 1 | 2013 | 270 | 0.020 |
Why?
|
Epithelium | 1 | 1995 | 1605 | 0.020 |
Why?
|
Angiofibroma | 1 | 2011 | 55 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11902 | 0.020 |
Why?
|
Pituitary Gland | 1 | 2013 | 637 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4902 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2015 | 749 | 0.020 |
Why?
|
Stem Cells | 1 | 2003 | 3524 | 0.020 |
Why?
|
Adolescent | 3 | 2014 | 87809 | 0.020 |
Why?
|
Pain | 1 | 2005 | 5066 | 0.020 |
Why?
|
Regeneration | 1 | 2019 | 1506 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14661 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2022 | 3200 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2315 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2860 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2020 | 2283 | 0.020 |
Why?
|
Chemokine CCL7 | 1 | 2008 | 30 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2001 | 8158 | 0.020 |
Why?
|
Immunochemistry | 1 | 2008 | 119 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2019 | 18955 | 0.020 |
Why?
|
beta-Defensins | 1 | 2008 | 59 | 0.020 |
Why?
|
Skull | 1 | 2013 | 815 | 0.020 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2011 | 286 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2014 | 1117 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2014 | 1723 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 1992 | 1232 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2017 | 1588 | 0.020 |
Why?
|
Antibodies | 1 | 1995 | 2421 | 0.020 |
Why?
|
RNA, Double-Stranded | 1 | 2008 | 295 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4897 | 0.020 |
Why?
|
Interferon-beta | 1 | 2008 | 345 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3618 | 0.020 |
Why?
|
Air | 1 | 2006 | 186 | 0.020 |
Why?
|
Tonsillitis | 1 | 2005 | 28 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5132 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2008 | 698 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5761 | 0.020 |
Why?
|
Interferons | 1 | 2008 | 705 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2470 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3315 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2825 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9716 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13505 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7022 | 0.010 |
Why?
|
Rats | 2 | 2001 | 23709 | 0.010 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2003 | 14 | 0.010 |
Why?
|
Interleukins | 1 | 2008 | 786 | 0.010 |
Why?
|
Neck Pain | 1 | 2005 | 186 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6831 | 0.010 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2003 | 60 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6544 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2003 | 72 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2754 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10442 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2008 | 999 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8552 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4046 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 2003 | 393 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10185 | 0.010 |
Why?
|
Cell Surface Extensions | 1 | 2001 | 66 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2008 | 2209 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6218 | 0.010 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2001 | 263 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11152 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 1835 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3280 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2008 | 3215 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24102 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3527 | 0.010 |
Why?
|
Fever | 1 | 2005 | 1617 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4356 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5039 | 0.010 |
Why?
|
Brain | 1 | 2021 | 26951 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12762 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 29957 | 0.010 |
Why?
|
Ultrasonics | 1 | 1992 | 207 | 0.010 |
Why?
|
United States | 1 | 2018 | 72448 | 0.010 |
Why?
|
Electrophysiology | 1 | 1992 | 1265 | 0.010 |
Why?
|
Muscles | 1 | 1992 | 1581 | 0.000 |
Why?
|
Electromyography | 1 | 1992 | 1388 | 0.000 |
Why?
|
Extremities | 1 | 1992 | 867 | 0.000 |
Why?
|
Movement | 1 | 1992 | 1474 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 9185 | 0.000 |
Why?
|
Child, Preschool | 1 | 2005 | 42056 | 0.000 |
Why?
|